Back to search
FDAFDA · Food and drugs·Recall number D-0434-2024

Cyclophosphamide for Injection, USP, 1g/vial, Lyophilized, Single Dose Vial, Discard unused solution, Cytotoxic Agent, After Reconstitution: For direct intravenous injection or must be further diluted before intravenous infusion, Rx Only, Manufactured for: XGen Pharmaceuticals DJB, Inc., Big Flats, NY 14814, NDC # 39822-0255-01.

Published April 10, 2024 · Recall initiated: April 2, 2024

Summary

FDA records drug Class III recall D-0434-2024, published April 10, 2024 and initiated April 2, 2024. Recalling firm: X-Gen Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 1332 vials; Lot: Lot #: CIC2-23001 A, Exp. 11/30/2026. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect or missing Package Insert: There is an error on the Package Insert (PI), section 2.3, Preparation, Handling, and Administration. The concentration of the reconstituted product is listed as '20 mg per vial.' This information should read: '20 mg per mL'.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
X-Gen Pharmaceuticals Inc.
Distributor
Nationwide in the US
Lot
Lot #: CIC2-23001 A, Exp. 11/30/2026
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cyclophosphamide for Injection, USP, 1g/vial, Lyophilized, Single Dose Vial, Discard unused solution, Cytotoxic Agent, After Reconstitution: For direct intravenous injection or must be further diluted before intravenous infusion, Rx Only, Manufactured for: XGen Pharmaceuticals DJB, Inc., Big Flats, NY 14814, NDC # 39822-0255-01. recalled?

Yes. FDA published recall D-0434-2024 on April 10, 2024. Reported hazard: Labeling: Incorrect or missing Package Insert: There is an error on the Package Insert (PI), section 2.3, Preparation, Handling, and Administration. The concentration of the reconstituted product is listed as '20 mg per vial.' This information should read: '20 mg per mL'.

What should I do if I have this product?

Voluntary: Firm initiated · Letter